Press Releases Items Per Page 102550 News Category FinancialGeneral Year None20252024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine Jun 02, 2015 Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the Jefferies 2015 Global Healthcare Conference in New York City May 28, 2015 Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 Apr 30, 2015 Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After Close of U.S.-Based Financial Markets Apr 23, 2015 Baxter Submits Application To Japan's MHLW For Approval Of BAX 855, Extended Half-Life Recombinant FVIII Based On ADVATE For Hemophilia A Apr 16, 2015 Nektar Therapeutics to Present at the 14th Annual Needham Healthcare Conference Apr 13, 2015 Nektar Announces Receipt of $100 Million Milestone Payment from AstraZeneca Apr 02, 2015 MOVANTIK™ (Naloxegol) Tablets For The Treatment Of Opioid-Induced Constipation In Adult Patients With Chronic Non-Cancer Pain Launched In The US Mar 31, 2015 AstraZeneca And Daiichi Sankyo To Jointly Commercialise MOVANTIK In The US Mar 19, 2015 Etirinotecan Pegol (NKTR-102) Prolonged Median Overall Survival by 2.1 Months versus Active Control in Patients with Advanced Breast Cancer in Phase 3 Study; Trial Did Not Achieve Statistical Significance (p=0.08) Mar 17, 2015 Pagination First page « first Previous page ‹ previous … Page 23 Page 24 Page 25 Page 26 Current page 27 Page 28 Page 29 Page 30 Page 31 … Next page next › Last page last »